Broadfin Capital

Broadfin Capital as of June 30, 2019

Portfolio Holdings for Broadfin Capital

Broadfin Capital holds 35 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Biohaven Pharmaceutical Holding 10.3 $47M 1.1M 43.79
Iovance Biotherapeutics (IOVA) 8.3 $38M 1.6M 24.52
Aratana Therapeutics 8.2 $38M 7.3M 5.16
Retrophin 7.4 $34M 1.7M 20.09
Nevro (NVRO) 6.9 $32M 488k 64.83
Mirati Therapeutics 4.5 $21M 200k 103.00
BioDelivery Sciences International 4.3 $20M 4.3M 4.65
Allergan 4.2 $19M 115k 167.43
Eiger Biopharmaceuticals 3.8 $18M 1.7M 10.60
Global Blood Therapeutics In 3.6 $17M 317k 52.60
Zogenix 3.6 $17M 345k 47.78
Recro Pharma (SCTL) 3.5 $16M 1.6M 10.17
Heron Therapeutics (HRTX) 3.1 $14M 758k 18.59
Catalyst Pharmaceutical Partners (CPRX) 2.3 $11M 2.8M 3.84
Dex (DXCM) 2.1 $9.5M 63k 149.84
Flamel Technologies Sa (AVDL) 1.9 $9.0M 3.1M 2.89
Sientra 1.9 $8.6M 1.4M 6.16
La Jolla Pharmaceuticl Com Par 1.8 $8.2M 892k 9.25
Strata Skin Sciences (SSKN) 1.8 $8.1M 3.3M 2.49
Strongbridge Bioph shs usd 1.7 $8.0M 2.5M 3.13
Viewray (VRAYQ) 1.7 $7.6M 867k 8.81
Sol Gel Technologies (SLGL) 1.4 $6.7M 730k 9.11
Si-bone (SIBN) 1.4 $6.4M 313k 20.34
Quotient 1.3 $6.0M 640k 9.35
Antares Pharma 1.2 $5.7M 1.7M 3.29
Incyte Corporation (INCY) 1.2 $5.7M 67k 84.95
Amarin Corporation (AMRN) 1.2 $5.6M 291k 19.39
Vericel (VCEL) 1.1 $4.9M 258k 18.89
Optinose (OPTN) 0.9 $4.2M 596k 7.08
Wright Medical Group Nv 0.8 $3.8M 126k 29.82
Myriad Genetics (MYGN) 0.8 $3.4M 124k 27.78
Adma Biologics (ADMA) 0.6 $2.9M 748k 3.87
Adamas Pharmaceuticals 0.6 $2.7M 441k 6.20
Nanostring Technologies (NSTGQ) 0.5 $2.3M 75k 30.35
Matinas Biopharma Holdings, In (MTNB) 0.1 $659k 767k 0.86